Printer Friendly

New Market Research Report: Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand.

[ClickPress, Tue Dec 08 2015]

In 2014-2015, allergy-related products continued to be made readily available in both tablet and in particular nasal spray format through supermarket and chemists/pharmacies channels. The 2014-2015 season for pollen allergies was very long and severe, resulting in high demand for allergy products.

Competitive Landscape

Reckitt Benckiser New Zealand Ltd leads cough, cold and allergy (hay fever) remedies in 2015 with a 25% value share. The leading brands include Lemsip, Strepsils and Nurofen. Lemsip (the leading brand) comprises a wide range of products including combination remedies and cough remedies. 2013 saw the launch of a range of pharmacy strength products, mainly focusing on relieving blocked sinuses. The leading brand in pharyngeal preparations is Lemsip. The company extended the basic range of Strepsils to include more specific throat lozenges (the main format for the brand) such as Children 6+ sugar and colour free and Sore Throat & Blocked nose, and extra strength formulations such as Strepsils Plus and Strepsils Intensive. In addition, the brand was expanded into throat sprays and cough syrups in the review period. Since entering cough, cold allergy (hay fever) remedies, the leading ibuprofen analgesic brand Nurofen saw an increase to reach 5% value share. Nurofen products include combination remedies such as Nurofen Cold & Flu PE and Nurofen Sinus Pain Relief for allergy-related symptoms and decongestion.

Full Report Details at

-

http://www.fastmr.com/prod/1082134_cough_cold_allergy_hay_fever.aspx?afid=301

Industry Prospects

Combining various formats and combination products is likely to evolve over the forecast period to relieve cold/flu and allergy sufferers. In particular, the use of tablets as well as nasal and throat sprays was a strong combination in 2015 and is likely to continue in the forecast period. Combination oral products that relieve a number of cold/flu symptoms will continue to be developed to help fever, aches and congestion as an all-in-one tablet. Other formats such as powdered sachets to make into a hot drink are also likely to continue, as they are seen as a traditional form of relief with a natural drink base such as lemon or honey.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in New Zealand with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in New Zealand, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand market research report includes:

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

Copyright [c] 2015 ClickPress Provided by SyndiGate Media Inc. ( Syndigate.info ).
COPYRIGHT 2015 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:ClickPress
Geographic Code:8NEWZ
Date:Dec 8, 2015
Words:535
Previous Article:Global Refractory Products Market 2015-2019 - New Study Released.
Next Article:New Report Available: Consumer Health in Germany.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |